Cushman & Wakefield Ltd. (CWK) Stock Price & How to Invest

Cushman & Wakefield is a global commercial real estate services firm with roughly 52,000 employees across close to 400 offices in about 60 countries, tracing its roots to 1784 and now headquartered in Chicago. It operates across four revenue lines: Services (facilities management, project management, and property management, the largest and steadiest piece at roughly $1.7 billion a quarter), Leasing (brokering office, industrial, and retail leases), Capital Markets (advising on property investment transactions and debt placement), and Valuation and other advisory work. It manages more than 1.1 billion square feet of commercial space and sits alongside CBRE, JLL, Newmark, and Colliers in the top tier of the industry.

The investment picture is a cyclical recovery story attached to a repaired balance sheet. Transaction-based revenue (Leasing and Capital Markets) carries far higher incremental margins than the outsourcing business, so when deal volumes turn, profit moves much faster than revenue: Q1 2026 revenue grew ~11% while adjusted EPS grew ~67%. Management under CEO Michelle MacKay has spent the past two years cutting debt, extending maturities, and hiring producer teams into the recovery, taking net leverage to ~3.1x from ~3.9x a year earlier. What keeps the multiple contained is that GAAP net income remains thin (~$74 million on ~$10.5 billion of trailing revenue), leverage is still meaningful, and the timing of a commercial property rebound depends on interest rates and credit conditions well outside the company's control.

The core risk is cyclicality: Leasing and Capital Markets revenue is tied to commercial property transaction volumes, which respond to interest rates, credit availability, and corporate confidence rather than anything the company controls. Leverage is still meaningful at ~$2.1 billion of net debt against a ~$3.2 billion market cap, so equity value is more sensitive to an earnings downturn than the headline multiple suggests. GAAP profitability remains thin, with trailing net income around $74 million and a Q1 2026 GAAP net loss driven by a ~$16.6 million pension settlement charge and a ~$11.8 million non-cash servicing liability, which makes reported earnings noisy and reliant on adjusted figures. Office exposure remains a structural overhang given hybrid work, and the firm competes with larger, better-capitalized rivals in CBRE and JLL that can outspend it on technology and recruiting. Ordinary-course litigation, including an ERISA suit over its own 401(k) plan and a class action following a 2026 data breach, adds headline and cost risk without being central to the thesis.

11 analysts publish price targets on CWK, averaging $17.44 against a $13.57 price as of August 2026, or +28.5%. The published targets run from $14.00 to $21.00, a moderate spread, and the ratings split 7 buy, 5 hold, 0 sell. Over the last six months there have been 0 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CWK forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Cushman & Wakefield Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Capital markets recovery leverage. Capital Markets revenue grew ~15% year over year in Q1 2026 to ~$182 million off a heavily depressed base, and management has described the recovery as a multiyear waterfall rather than a single snap-back. The most optimistic published target, $21.00, assumes this works close to its best case.

The case against. The core risk is cyclicality: Leasing and Capital Markets revenue is tied to commercial property transaction volumes, which respond to interest rates, credit availability, and corporate confidence rather than anything the company controls. The most pessimistic target, $14.00, is roughly what CWK is worth if this bites instead.

Read the full bull and bear case on CWK, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Cushman & Wakefield Ltd.'s investor relations page or your broker.

• Revenue (TTM): ~$10.5B (+10% YoY)
• Q1 2026 revenue: ~$2.54B (+11% YoY)
• Q1 2026 adjusted EBITDA: ~$111M (+16% YoY)
• Market cap: ~$3.2B
• P/E (trailing / forward): ~43x / ~9x
• Net leverage: ~3.1x (from ~3.9x YoY)

The gap between a trailing P/E in the low 40s and a forward P/E around 9 is the whole valuation debate in one number: trailing GAAP earnings are depressed by non-cash charges and a still-recovering transaction market, while the forward figure assumes management's guidance for ~6% to 8% revenue growth and ~15% to 20% adjusted EPS growth in 2026 lands. The stock trades around $13.57 as of early August 2026, inside a 52-week range of roughly $11.57 to $17.40, with a beta near 1.44 that reflects how tightly it tracks property cycle sentiment. Q2 2026 results are due on August 5, 2026, with consensus revenue near $2.65 billion.

Other names that sit close to CWK: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CWK exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CWK sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CWK fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Cushman & Wakefield is a scale player in commercial real estate services whose earnings are geared to a capital markets recovery, so the debate is whether the deleveraging and transaction rebound arrive faster than the cycle can interrupt them.

Whether CWK is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CWK a buy or a sell?, and where the stock could go from here in the CWK stock forecast.

For income investors, whether CWK pays a dividend and how the payout looks is covered in does CWK pay a dividend? And to weigh CWK against a peer, read the full side-by-side comparisons: CWK vs CBRE and CWK vs JLL.